Amphastar Pharmaceuticals (AMPH) Capital Expenditures (QoQ) (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) Capital Expenditures (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Amphastar Pharmaceuticals | 855.23 Mn | 684.09 Mn | 70.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.54% |
| Dec 31, 2025 | -59.76% |
| Sep 30, 2025 | 1,865.98% |
| Jun 30, 2025 | -116.13% |
| Mar 31, 2025 | -79.91% |
| Dec 31, 2024 | 2,331.12% |
| Sep 30, 2024 | 21.96% |
| Jun 30, 2024 | -123.46% |
| Mar 31, 2024 | 136.23% |
| Dec 31, 2023 | -338.10% |
| Sep 30, 2023 | 12.58% |
| Jun 30, 2023 | -4.46% |
| Mar 31, 2023 | 419.29% |
| Dec 31, 2022 | 121.05% |
| Sep 30, 2022 | -260.79% |
| Jun 30, 2022 | -19.63% |
| Mar 31, 2022 | -2.46% |
| Dec 31, 2021 | -49.22% |
| Sep 30, 2021 | 1,601.51% |
| Jun 30, 2021 | -87.24% |